Details for Patent: 5,169,849
✉ Email this page to a colleague
Summary for Patent: 5,169,849
Title: | Nasal pharmaceutical compositions |
Abstract: | A nasal pharmaceutical composition incorporates a non-toxic agent which is capable of increasing the ciliary function e.g. caffeine and at least partially antagonizing the ciliary function depressant effect of the active agent e.g. dihydroergotamine or any other constituent present in the composition. |
Inventor(s): | Kiechel; Jean-Rene (Rueil-Malmaison, FR), Acezat-Mispelter; Francoise (Elancourt, FR), Plas; Danielle (Rueil-Malmaison, FR) |
Assignee: | Sandoz Ltd. (Basel, CH) |
Application Number: | 07/603,990 |
Patent Claim Types: see list of patent claims | Composition; Compound; Formulation; Dosage form; Delivery; Use; | More… ↓ |
Drugs Protected by US Patent 5,169,849
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,169,849
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 8202781 | Feb 01, 1982 |
International Family Members for US Patent 5,169,849
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 385656 | ⤷ Subscribe | |||
Austria | A30383 | ⤷ Subscribe | |||
Australia | 1085083 | ⤷ Subscribe | |||
Australia | 565613 | ⤷ Subscribe | |||
Belgium | 895750 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |